Description: Bora Pharmaceuticals Co., LTD. engages in the research, development, production, marketing, sale, and distribution of pharmaceutical products worldwide. It manufactures and sells generic, brand, and over-the-counter (OTC) drugs. The company is involved in contract development and manufacturing; consumer healthcare and OTC; and prescription drugs businesses. It also provides clinical and commercial manufacturing services, including solvent manufacturing; solid and liquid dosage forms; extrusion spheronization; immediate and extended release; core, sugar-coated, and film-coated tablets; fixed-dose combination products; and granules, and liquids sachet/stick pack filling. In addition, the company offers pharmaceutical development services, such as liquid and solid dosage forms, and immediate and modified release, analytical method development and validation; packaging and serialization services, which include bottle and blister packaging, and sachets; and raw materials and finished products testing, and analytical techniques services, as well as method verification, validation, and transfer. Further, it provides OTC medicines, foods and vitamins supplements; and skincare products. Additionally, the company offers market analysis, drug and regulatory related services, price development, GDP warehousing, distribution, packaging, marketing planning, and sales services. The company's sales and distribution network comprising of medical centers, hospitals, clinics, pharmacies, drug stores, CVS, and specialty channels. Bora Pharmaceuticals Co., LTD. was incorporated in 2007 and is based in Taipei, Taiwan.
Home Page: www.bora-corp.com
26, Ruiguang Road
Taipei,
114
Taiwan
Phone:
886 2 2790 1555
Officers
| Name | Title |
|---|---|
| Mr. Pao-Shi Sheng | Chairman, GM & CEO |
| Ms. Alice Wang | CFO of HQ & APAC |
| Ellen Chen | Corp. Human Resource Director |
| Mr. Shih-Min Chen | VP & Director |
| Ms. Sally Langa | Sr. VP of Marketing and Sales - CDMO Bus. |
| Mr. Marcel Vieno | CFO of North America |
Exchange: TWO
Country: TW
Currency: New Taiwan Dollar (NT$)
| Forward PE: | 0 |
|---|---|
| Trailing PE: | 25.721 |
| Price-to-Book MRQ: | 7.2443 |
| Price-to-Sales TTM: | 4.5198 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 0 |